Stoke Therapeutics, Inc.
STOKNasdaqCIK 1623526HealthcareFiscal year ends Dec 31
Reports and events: 137 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2916:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-437775 |
| 2026-09-2516:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-402820 |
| 2026-08-0317:06 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-330804 |
| 2026-08-0316:07 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-330557 |
| 2026-08-0316:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-330537 |
| 2026-06-3008:02 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-289409 |
| 2026-06-0416:08 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-257394 |
| 2026-05-0716:19 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-212020 |
| 2026-05-0716:06 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-211874 |
| 2026-04-2216:05 ET | DEF 14A | Proxy statementPeriod 2026-06-03 | 0001193125-26-170362 |
| 2026-04-0716:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-145524 |
| 2026-03-2716:30 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001193125-26-129168 |
| 2026-03-1616:15 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-108362 |
| 2026-03-0316:11 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-088205 |
| 2026-01-2616:06 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation | 0001193125-26-022569 |
| 2026-01-1207:34 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-009781 |
| 2025-12-0509:05 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-308781 |
| 2025-11-0416:16 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-264720 |
| 2025-11-0416:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-264644 |
| 2025-10-0607:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-25-230925 |
| 2025-09-1816:07 ET | 8-K/A | 5.07 Shareholder vote results | 0001193125-25-207401 |
| 2025-08-2617:42 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001123292-25-000387 |
| 2025-08-1216:16 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-107332 |
| 2025-08-1216:01 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-107275 |
| 2025-08-1107:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-177433 |
| 2025-07-1007:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-157364 |
| 2025-06-2316:47 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001123292-25-000298 |
| 2025-06-0616:23 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001123292-25-000272 |
| 2025-06-0416:05 ET | 8-K | 5.07 Shareholder vote results | 0001193125-25-134882 |
| 2025-06-0407:00 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-134447 |
| 2025-05-1316:05 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-070296 |
| 2025-05-1307:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-069783 |
| 2025-04-2216:05 ET | DEF 14A | Proxy statementPeriod 2025-06-03 | 0001193125-25-089188 |
| 2025-03-1816:05 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-041170 |
| 2025-03-1807:05 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-040758 |
| 2025-02-1816:31 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-028650 |
| 2025-01-0707:06 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-002550 |
| 2024-12-2717:23 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001123292-24-000417 |
| 2024-12-0617:19 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-272559 |
| 2024-11-0516:05 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-121445 |
| 2024-11-0507:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-121068 |
| 2024-09-2316:22 ET | SC 13D/A | Ownership report, active investor, amended | 0001123292-24-000282 |
| 2024-09-1016:17 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-216632 |
| 2024-08-0716:05 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-092738 |
| 2024-08-0707:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-092268 |
| 2024-06-2116:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-24-165651 |
| 2024-06-0616:06 ET | 8-K | 5.07 Shareholder vote results | 0001193125-24-156049 |
| 2024-05-0616:05 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-053535 |
| 2024-05-0607:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-053195 |
| 2024-04-2916:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-24-122215 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 16:06 ET. Listed shows no prices and gives no investment advice.